Non-Hodgkin Lymphoma​

Non-Hodgkin Lymphoma (NHL)

More than 400 clinical trials are currently accepting participants diagnosed with Non-Hodgkin Lymphoma​.

Non-Hodgkin Lymphoma (NHL) is a type of cancer that develops in the lymphatic system, a crucial part of the immune system. It specifically affects a type of white blood cell known as lymphocytes, which play a vital role in fighting infections. It's important to note that NHL is different from Hodgkin Lymphoma, both in its cellular characteristics and in how it is treated. NHL generally does not contain the Reed-Sternberg cells that are typical of Hodgkin Lymphoma. The treatment and prognosis for NHL can be very different from Hodgkin Lymphoma

What clinical trials are

Learn more

Before you take part in a clinical trial

Learn more

Find the right clinical trial

Learn more